2013-03-07 09:47:50 - “First trimester prenatal testing is expected to show sustained growth in the US on account of its screening capabilities “, says RNCOS.
According to a new research report by RNCOS entitled, “Prenatal Testing Market Outlook 2015”, the first trimester prenatal testing is expected to show sustained growth in the US on account of their screening capabilities. First trimester testing proves as an effective means of early chromosomal abnormality screening and have high demand amongst the pregnant population. A major driver for the sustained growth of these screening methodologies is the growing awareness and rising health concerns in the US; with blood tests being the most common category of tests undergone by pregnant women.
With rising concerns over fetal and maternal health, prenatal testing in the US has seen promising developments and government initiatives augmenting growth in the industry. The increase in the incidence
of chromosomal abnormalities and inheritance of familial genetic disorders has created the much need for prenatal testing. Invasive techniques, such as CVS and amniocentesis are declining and active research and development is happening to produce non-invasive prenatal tests. According to latest report by RNCOS, “Prenatal Testing Market Analysis”, second trimester prenatal testing conducted during 15-18 weeks of pregnancy are in particular expected to show robust growth.
The report, which is spread over 40 pages, provides an in-depth research and rational analysis of the current and expected status of the prenatal testing market in the US. The report provides an understanding of the major prenatal tests involved in the US for both screening and diagnostic purposes. The current and future forecasts for each market segment have been presented to provide the market progress in the coming years along with expected growth in the overall industry. Prevailing industry trends and drivers have been compiled. Regulatory scenario analysis has also been provided. Key competitor analysis also provides an understanding of the major players and their portfolio of testing services provided for prenatal testing.
For FREE SAMPLE of this report visit: www.rncos.com/Report/IM415.htm
Some of our Related Reports are:
- US Telelaparoscopy Opportunity Analysis ( www.rncos.com/Report/IM469.htm
- US Proton Therapy Market Analysis to 2017 ( www.rncos.com/Report/IM465.htm
- US Personalized Cancer Genome Sequencing Market ( www.rncos.com/Report/IM453.htm
- Brazil Healthcare - New Opportunities for Growth ( www.rncos.com/Report/IM451.htm
- US Non-Invasive Prenatal Diagnostics - Market Insight ( www.rncos.com/Report/IM450.htm
Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.